These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 34192324)

  • 1. Regulatory Approaches and Implementation of Minimally Addictive Combusted Products.
    Hatsukami DK; Xu D; Ferris Wayne G
    Nicotine Tob Res; 2022 Mar; 24(4):453-462. PubMed ID: 34192324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the evidence on cigarettes with reduced addictiveness potential.
    Donny EC; White CM
    Int J Drug Policy; 2022 Jan; 99():103436. PubMed ID: 34535366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends and Patterns of Tobacco and Nicotine Product Use Among Youth in Canada, England, and the United States From 2017 to 2019.
    East KA; Reid JL; Rynard VL; Hammond D
    J Adolesc Health; 2021 Sep; 69(3):447-456. PubMed ID: 33839006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing the nicotine content of combusted tobacco products sold in New Zealand.
    Donny EC; Walker N; Hatsukami D; Bullen C
    Tob Control; 2017 Mar; 26(e1):e37-e42. PubMed ID: 27672126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public Health Policies on E-Cigarettes.
    Bhalerao A; Sivandzade F; Archie SR; Cucullo L
    Curr Cardiol Rep; 2019 Aug; 21(10):111. PubMed ID: 31463564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies to Reduce Illicit Trade of Regular Nicotine Tobacco Products After Introduction of a Low-Nicotine Tobacco Product Standard.
    Ribisl KM; Hatsukami DK; Huang J; Williams RS; Donny EC
    Am J Public Health; 2019 Jul; 109(7):1007-1014. PubMed ID: 31166743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions to reduce harm from continued tobacco use.
    Lindson-Hawley N; Hartmann-Boyce J; Fanshawe TR; Begh R; Farley A; Lancaster T
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005231. PubMed ID: 27734465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.
    Thomas KH; Dalili MN; López-López JA; Keeney E; Phillippo D; Munafò MR; Stevenson M; Caldwell DM; Welton NJ
    Health Technol Assess; 2021 Oct; 25(59):1-224. PubMed ID: 34668482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of Non-Cigarette Tobacco and Nicotine Use Among Current Cigarette Smokers and Recent Quitters: Findings From the 2020 ITC Four Country Smoking and Vaping Survey.
    Li L; Borland R; Cummings KM; Gravely S; Quah ACK; Fong GT; Miller CR; Goniewicz ML; Le Grande M; McNeill A
    Nicotine Tob Res; 2021 Aug; 23(9):1611-1616. PubMed ID: 33693833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smokers' behavioral intentions in response to a low-nicotine cigarette policy.
    Patel M; Cuccia AF; Czaplicki L; Donovan EM; Simard B; Pitzer L; Hair EC; Schillo BA; Vallone DM
    Drug Alcohol Depend; 2019 Dec; 205():107645. PubMed ID: 31704376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing the addictiveness of cigarettes. Council on Scientific Affairs, American Medical Association.
    Henningfield JE; Benowitz NL; Slade J; Houston TP; Davis RM; Deitchman SD
    Tob Control; 1998; 7(3):281-93. PubMed ID: 9825424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moving targets: how the rapidly changing tobacco and nicotine landscape creates advertising and promotion policy challenges.
    Ling PM; Kim M; Egbe CO; Patanavanich R; Pinho M; Hendlin Y
    Tob Control; 2022 Mar; 31(2):222-228. PubMed ID: 35241592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The past is not the future in tobacco control.
    Cummings KM; Ballin S; Sweanor D
    Prev Med; 2020 Nov; 140():106183. PubMed ID: 32603797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Reduced-Nicotine Cigarettes Across Regulatory Environments in the Experimental Tobacco Marketplace: A Randomized Trial.
    Kaplan BA; Koffarnus MN; Franck CT; Bickel WK
    Nicotine Tob Res; 2021 Jun; 23(7):1123-1132. PubMed ID: 33165612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: 5
    Higgins ST
    Prev Med; 2018 Dec; 117():1-4. PubMed ID: 30340697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are we guilty of errors of omission on the potential role of electronic nicotine delivery systems as less harmful substitutes for combusted tobacco use?
    Henningfield JE; Higgins ST; Villanti AC
    Prev Med; 2018 Dec; 117():83-87. PubMed ID: 30261245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Proposed Policy Agenda For Electronic Cigarettes In The US: Product, Price, Place, And Promotion.
    Warner KE; Kiessling KA; Douglas CE; Liber AC
    Health Aff (Millwood); 2022 Sep; 41(9):1299-1306. PubMed ID: 36067433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-cigarettes compared with nicotine replacement therapy within the UK Stop Smoking Services: the TEC RCT.
    Hajek P; Phillips-Waller A; Przulj D; Pesola F; Smith KM; Bisal N; Li J; Parrott S; Sasieni P; Dawkins L; Ross L; Goniewicz M; Wu Q; McRobbie HJ
    Health Technol Assess; 2019 Aug; 23(43):1-82. PubMed ID: 31434605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing the nicotine content to make cigarettes less addictive.
    Benowitz NL; Henningfield JE
    Tob Control; 2013 May; 22 Suppl 1(Suppl 1):i14-7. PubMed ID: 23591498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Framing Nicotine Reduction in Cigarettes on Anticipated Tobacco Product Use Intentions and Risk Perceptions Among US Adult Smokers.
    Popova L; Owusu D; Nyman AL; Weaver SR; Yang B; Huang J; Ashley DL
    Nicotine Tob Res; 2019 Dec; 21(Suppl 1):S108-S116. PubMed ID: 31867652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.